• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤微环境中 CD8 T 细胞耗竭及其调控机制:免疫治疗成功的关键。

CD8 T cell exhaustion and its regulatory mechanisms in the tumor microenvironment: key to the success of immunotherapy.

机构信息

Department of General Surgery, Clinical Laboratory of Integrative Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, China.

Department of Oncology, First Affiliated Hospital of Dalian Medical University, Dalian, China.

出版信息

Front Immunol. 2024 Sep 20;15:1476904. doi: 10.3389/fimmu.2024.1476904. eCollection 2024.

DOI:10.3389/fimmu.2024.1476904
PMID:39372416
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11452849/
Abstract

A steady dysfunctional state caused by chronic antigen stimulation in the tumor microenvironment (TME) is known as CD8 T cell exhaustion. Exhausted-like CD8 T cells (CD8 Tex) displayed decreased effector and proliferative capabilities, elevated co-inhibitory receptor generation, decreased cytotoxicity, and changes in metabolism and transcription. TME induces T cell exhaustion through long-term antigen stimulation, upregulation of immune checkpoints, recruitment of immunosuppressive cells, and secretion of immunosuppressive cytokines. CD8 Tex may be both the reflection of cancer progression and the reason for poor cancer control. The successful outcome of the current cancer immunotherapies, which include immune checkpoint blockade and adoptive cell treatment, depends on CD8 Tex. In this review, we are interested in the intercellular signaling network of immune cells interacting with CD8 Tex. These findings provide a unique and detailed perspective, which is helpful in changing this completely unpopular state of hypofunction and intensifying the effect of immunotherapy.

摘要

由肿瘤微环境(TME)中慢性抗原刺激引起的稳定功能障碍状态被称为 CD8 T 细胞耗竭。耗竭样 CD8 T 细胞(CD8 Tex)表现出效应和增殖能力下降、共抑制受体生成增加、细胞毒性降低以及代谢和转录改变。TME 通过长期抗原刺激、免疫检查点上调、抑制性细胞募集和抑制性细胞因子分泌诱导 T 细胞耗竭。CD8 Tex 既可能是癌症进展的反映,也可能是癌症控制不佳的原因。当前癌症免疫疗法的成功结果,包括免疫检查点阻断和过继细胞治疗,取决于 CD8 Tex。在这篇综述中,我们对与 CD8 Tex 相互作用的免疫细胞的细胞间信号网络感兴趣。这些发现提供了一个独特而详细的视角,有助于改变这种完全不受欢迎的低功能状态,并增强免疫疗法的效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51e0/11452849/31045671cb32/fimmu-15-1476904-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51e0/11452849/a31289e16383/fimmu-15-1476904-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51e0/11452849/31045671cb32/fimmu-15-1476904-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51e0/11452849/a31289e16383/fimmu-15-1476904-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51e0/11452849/31045671cb32/fimmu-15-1476904-g002.jpg

相似文献

1
CD8 T cell exhaustion and its regulatory mechanisms in the tumor microenvironment: key to the success of immunotherapy.肿瘤微环境中 CD8 T 细胞耗竭及其调控机制:免疫治疗成功的关键。
Front Immunol. 2024 Sep 20;15:1476904. doi: 10.3389/fimmu.2024.1476904. eCollection 2024.
2
Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy.肿瘤免疫微环境中耗竭的CD8 + T细胞:新的治疗途径
Front Immunol. 2021 Feb 2;11:622509. doi: 10.3389/fimmu.2020.622509. eCollection 2020.
3
The tumor microenvironment shapes the molecular characteristics of exhausted CD8 T cells.肿瘤微环境塑造衰竭 CD8 T 细胞的分子特征。
Cancer Lett. 2021 May 28;506:55-66. doi: 10.1016/j.canlet.2021.02.013. Epub 2021 Mar 2.
4
Reversal of T-cell exhaustion: Mechanisms and synergistic approaches.T 细胞耗竭的逆转:机制与协同策略。
Int Immunopharmacol. 2024 Sep 10;138:112571. doi: 10.1016/j.intimp.2024.112571. Epub 2024 Jun 27.
5
T cell exhaustion in human cancers.人类癌症中的 T 细胞耗竭。
Biochim Biophys Acta Rev Cancer. 2024 Sep;1879(5):189162. doi: 10.1016/j.bbcan.2024.189162. Epub 2024 Jul 30.
6
Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8 T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy.Eomes 依赖性共激活受体 CD226 的缺失抑制 CD8 T 细胞的抗肿瘤功能,并限制癌症免疫疗法的疗效。
Immunity. 2020 Oct 13;53(4):824-839.e10. doi: 10.1016/j.immuni.2020.09.006.
7
Impact of CD4 T cells on intratumoral CD8 T-cell exhaustion and responsiveness to PD-1 blockade therapy in mouse brain tumors.CD4 T 细胞对脑肿瘤内 CD8 T 细胞耗竭和对 PD-1 阻断治疗反应性的影响。
J Immunother Cancer. 2022 Dec;10(12). doi: 10.1136/jitc-2022-005293.
8
New insights into T-cell exhaustion in liver cancer: from mechanism to therapy.肝癌中 T 细胞耗竭的新见解:从机制到治疗。
J Cancer Res Clin Oncol. 2023 Oct;149(13):12543-12560. doi: 10.1007/s00432-023-05083-5. Epub 2023 Jul 9.
9
CD8 T Cell Exhaustion in Cancer.癌症中的 CD8 T 细胞耗竭。
Front Immunol. 2021 Jul 20;12:715234. doi: 10.3389/fimmu.2021.715234. eCollection 2021.
10
Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumors.肿瘤内免疫三联体是免疫治疗介导的实体瘤消除所必需的。
Cancer Cell. 2024 Jul 8;42(7):1202-1216.e8. doi: 10.1016/j.ccell.2024.05.025. Epub 2024 Jun 20.

引用本文的文献

1
Exploration of the Roles and Mechanisms Between Tumor-Infiltrating Lymphocytes and Hepatocellular Carcinoma Based on Single-Cell Transcriptomics.基于单细胞转录组学探究肿瘤浸润淋巴细胞与肝细胞癌之间的作用及机制
Int J Genomics. 2025 Aug 20;2025:1575734. doi: 10.1155/ijog/1575734. eCollection 2025.
2
Vinburnine potentiates anti-PD1 immunotherapy in melanoma through IL-24 secretion via P38/MAPK/ATF3 signaling.长春宾碱通过P38/MAPK/ATF3信号通路分泌白细胞介素-24,增强黑色素瘤中抗PD1免疫疗法的疗效。
J Exp Clin Cancer Res. 2025 Aug 27;44(1):255. doi: 10.1186/s13046-025-03521-5.
3
Spatial transcriptomics and scRNA-seq: decoding tumor complexity and constructing prognostic models in colorectal cancer.

本文引用的文献

1
Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumors.新辅助 PARPi 或化疗在卵巢癌中告知靶向效应 Treg 细胞同源重组缺陷肿瘤。
Cell. 2024 Sep 5;187(18):4905-4925.e24. doi: 10.1016/j.cell.2024.06.013. Epub 2024 Jul 5.
2
Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumors.肿瘤内免疫三联体是免疫治疗介导的实体瘤消除所必需的。
Cancer Cell. 2024 Jul 8;42(7):1202-1216.e8. doi: 10.1016/j.ccell.2024.05.025. Epub 2024 Jun 20.
3
EBV promotes TCR-T-cell therapy resistance by inducing CD163+M2 macrophage polarization and MMP9 secretion.
空间转录组学与单细胞RNA测序:解析结直肠癌的肿瘤复杂性并构建预后模型
Hum Genomics. 2025 Aug 13;19(1):92. doi: 10.1186/s40246-025-00805-x.
4
Downregulation of PGK1 promotes lipid peroxidation and suppresses proliferation in cervical cancer revealed by liquid-liquid phase separation-related gene signature.液-液相分离相关基因特征揭示PGK1下调促进宫颈癌脂质过氧化并抑制增殖
BMC Cancer. 2025 Aug 5;25(1):1269. doi: 10.1186/s12885-025-14637-4.
5
PD-1/PD-L1 inhibitors monotherapy vs. combination therapy in elderly advanced NSCLC: a real-world study and nomogram for survival prognosis.老年晚期非小细胞肺癌中PD-1/PD-L1抑制剂单药治疗与联合治疗的比较:一项生存预后的真实世界研究及列线图
BMC Pulm Med. 2025 Jul 23;25(1):350. doi: 10.1186/s12890-025-03791-x.
6
Integrating pan-immune-inflammation value into personalized survival prediction of nasopharyngeal carcinoma: a large-scale long-term retrospective study.将泛免疫炎症值纳入鼻咽癌个性化生存预测:一项大规模长期回顾性研究
BMC Cancer. 2025 Jul 21;25(1):1194. doi: 10.1186/s12885-025-14413-4.
7
Blocking secretion of exosomes by GW4869 dampens CD8 T cell exhaustion and prostate cancer progression.GW4869阻断外泌体分泌可抑制CD8 T细胞耗竭和前列腺癌进展。
Hum Cell. 2025 Jul 18;38(5):131. doi: 10.1007/s13577-025-01257-0.
8
The impact of neddylation on prognosis in the immune microenvironment of neuroblastoma: a single-cell transcriptomic analysis.Neddylation对神经母细胞瘤免疫微环境中预后的影响:一项单细胞转录组分析
Immunol Res. 2025 Jul 17;73(1):107. doi: 10.1007/s12026-025-09662-1.
9
Improvement of the Anticancer Efficacy of PD-1/PD-L1 Blockade: Advances in Molecular Mechanisms and Therapeutic Strategies.PD-1/PD-L1阻断疗法抗癌疗效的改善:分子机制与治疗策略的进展
MedComm (2020). 2025 Jul 15;6(8):e70274. doi: 10.1002/mco2.70274. eCollection 2025 Aug.
10
Characteristics and predictive model for diffuse large B-cell lymphoma with early chemoimmunotherapy failure.早期化疗免疫治疗失败的弥漫性大B细胞淋巴瘤的特征及预测模型
Front Immunol. 2025 Jun 16;16:1553850. doi: 10.3389/fimmu.2025.1553850. eCollection 2025.
EBV 通过诱导 CD163+M2 巨噬细胞极化和 MMP9 分泌促进 TCR-T 细胞治疗耐药性。
J Immunother Cancer. 2024 Jun 17;12(6):e008375. doi: 10.1136/jitc-2023-008375.
4
CD147-K148me2-Driven Tumor Cell-Macrophage Crosstalk Provokes NSCLC Immunosuppression via the CCL5/CCR5 Axis.CD147-K148me2 驱动的肿瘤细胞-巨噬细胞串扰通过 CCL5/CCR5 轴引发 NSCLC 免疫抑制。
Adv Sci (Weinh). 2024 Aug;11(29):e2400611. doi: 10.1002/advs.202400611. Epub 2024 Jun 14.
5
Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategies.肠道微生物群重塑癌症免疫治疗疗效:机制与治疗策略。
Imeta. 2024 Jan 1;3(1):e156. doi: 10.1002/imt2.156. eCollection 2024 Feb.
6
Interruption of the intratumor CD8 T cell:Treg crosstalk improves the efficacy of PD-1 immunotherapy.阻断肿瘤内 CD8 T 细胞:Treg 细胞串扰可提高 PD-1 免疫治疗的疗效。
Cancer Cell. 2024 Jun 10;42(6):1051-1066.e7. doi: 10.1016/j.ccell.2024.05.013.
7
PI3Kγ inhibition combined with DNA vaccination unleashes a B-cell-dependent antitumor immunity that hampers pancreatic cancer.PI3Kγ 抑制联合 DNA 疫苗接种释放出依赖 B 细胞的抗肿瘤免疫,从而抑制胰腺癌。
J Exp Clin Cancer Res. 2024 Jun 1;43(1):157. doi: 10.1186/s13046-024-03080-1.
8
Human 3D Ovarian Cancer Models Reveal Malignant Cell-Intrinsic and -Extrinsic Factors That Influence CAR T-cell Activity.人类3D卵巢癌模型揭示影响CAR T细胞活性的恶性细胞内在和外在因素。
Cancer Res. 2024 Aug 1;84(15):2432-2449. doi: 10.1158/0008-5472.CAN-23-3007.
9
Expression of CD39 is associated with T cell exhaustion in ovarian cancer and its blockade reverts T cell dysfunction.CD39 的表达与卵巢癌中 T 细胞耗竭相关,其阻断可恢复 T 细胞功能障碍。
Oncoimmunology. 2024 May 9;13(1):2346359. doi: 10.1080/2162402X.2024.2346359. eCollection 2024.
10
BET inhibition sensitizes innate checkpoint inhibitor resistant melanoma to anti-CTLA-4 treatment.BET 抑制使先天检查点抑制剂耐药的黑色素瘤对抗 CTLA-4 治疗敏感。
Pigment Cell Melanoma Res. 2024 Nov;37(6):744-751. doi: 10.1111/pcmr.13174. Epub 2024 May 9.